BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21521350)

  • 1. Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers.
    Andersen B; Beck-Nielsen H; Højlund K
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):514-9. PubMed ID: 21521350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
    Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans.
    Yu H; Xia F; Lam KS; Wang Y; Bao Y; Zhang J; Gu Y; Zhou P; Lu J; Jia W; Xu A
    Clin Chem; 2011 May; 57(5):691-700. PubMed ID: 21325103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.
    Gälman C; Lundåsen T; Kharitonenkov A; Bina HA; Eriksson M; Hafström I; Dahlin M; Amark P; Angelin B; Rudling M
    Cell Metab; 2008 Aug; 8(2):169-74. PubMed ID: 18680716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes.
    Lu J; Yu H; Mo Y; Ma X; Hao Y; Lu W; Li H; Bao Y; Zhou J; Jia W
    PLoS One; 2015; 10(11):e0142207. PubMed ID: 26540514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian variation in glucose tolerance and associated changes in plasma insulin and somatostatin levels in normal volunteers.
    Verrillo A; de Teresa A; Rucco E
    Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2261-6. PubMed ID: 6152172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-imposed daily restricted feeding induces rhythmic expression of Fgf21 in white adipose tissue of mice.
    Oishi K; Konishi M; Murata Y; Itoh N
    Biochem Biophys Res Commun; 2011 Aug; 412(2):396-400. PubMed ID: 21835167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans.
    Lundberg J; Höybye C; Krusenstjerna-Hafstrøm T; Bina HA; Kharitonenkov A; Angelin B; Rudling M
    J Intern Med; 2013 Sep; 274(3):227-32. PubMed ID: 23844970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia.
    Kim SP; Catalano KJ; Hsu IR; Chiu JD; Richey JM; Bergman RN
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1590-8. PubMed ID: 17264230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired modulation of hepatic glucose output overnight after a 72-h fast in normal man.
    Clore JN; Helm ST; Nestler JE; Blackard WG
    J Clin Endocrinol Metab; 1990 Apr; 70(4):865-8. PubMed ID: 2180979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin.
    Mai K; Bobbert T; Groth C; Assmann A; Meinus S; Kraatz J; Andres J; Arafat AM; Pfeiffer AF; Möhlig M; Spranger J
    Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E126-30. PubMed ID: 20424140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice.
    Li X; Ge H; Weiszmann J; Hecht R; Li YS; Véniant MM; Xu J; Wu X; Lindberg R; Li Y
    FEBS Lett; 2009 Oct; 583(19):3230-4. PubMed ID: 19751733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
    Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
    Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin-mediated effects of undernutrition or fasting on luteinizing hormone and growth hormone secretion in ovariectomized ewes depend on the duration of metabolic perturbation.
    Henry BA; Goding JW; Tilbrook AJ; Dunshea FR; Blache D; Clarke IJ
    J Neuroendocrinol; 2004 Mar; 16(3):244-55. PubMed ID: 15049855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fasting on insulin action and glucose kinetics in lean and obese men and women.
    Bergman BC; Cornier MA; Horton TJ; Bessesen DH
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1103-11. PubMed ID: 17684102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for increased sensitivity of fuel mobilization to growth hormone during short-term fasting in humans.
    Møller N; Pørksen N; Ovesen P; Alberti KG
    Horm Metab Res; 1993 Mar; 25(3):175-9. PubMed ID: 8477956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal rhythms in plasma glucose, insulin, growth hormone and melatonin levels in fasted and hyperglycaemic rats.
    Bizot-Espiard JG; Doublé A; Guardiola-Lemaitre B; Delagrange P; Ktorza A; Pénicaud L
    Diabetes Metab; 1998 Jun; 24(3):235-40. PubMed ID: 9690056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man.
    Gerich JE; Langlois M; Schneider V; Karam JH; Noacco C
    J Clin Invest; 1974 May; 53(5):1284-9. PubMed ID: 4825225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.